193 related articles for article (PubMed ID: 31769248)
1. Serum Procollagen Type I N-Terminal Propeptide and Osteocalcin Levels in Korean Children and Adolescents.
Choi JS; Park I; Lee SJ; Ju HJ; Lee H; Kim J
Yonsei Med J; 2019 Dec; 60(12):1174-1180. PubMed ID: 31769248
[TBL] [Abstract][Full Text] [Related]
2. Reference values of osteocalcin and procollagen type I N-propeptide plasma levels in a healthy Central European population aged 0-18 years.
Bayer M
Osteoporos Int; 2014 Feb; 25(2):729-36. PubMed ID: 23974858
[TBL] [Abstract][Full Text] [Related]
3. A cross-sectional study on biochemical parameters of bone turnover and vitamin d metabolites in healthy dutch children and young adults.
van der Sluis IM; Hop WC; van Leeuwen JP; Pols HA; de Muinck Keizer-Schrama SM
Horm Res; 2002; 57(5-6):170-9. PubMed ID: 12053089
[TBL] [Abstract][Full Text] [Related]
4. Reference intervals of β-C-terminal telopeptide of type I collagen, procollagen type I N-terminal propeptide and osteocalcin for very elderly Chinese men.
Shou Z; Jin X; Bian P; Li X; Chen J
Geriatr Gerontol Int; 2017 May; 17(5):773-778. PubMed ID: 27137883
[TBL] [Abstract][Full Text] [Related]
5. Decreased markers of bone turnover in children and adolescents with type 1 diabetes.
Madsen JOB; Herskin CW; Zerahn B; Jørgensen NR; Olsen BS; Pociot F; Johannesen J
Pediatr Diabetes; 2020 May; 21(3):505-514. PubMed ID: 31970841
[TBL] [Abstract][Full Text] [Related]
6. Zinc Supplementation Increases Procollagen Type 1 Amino-Terminal Propeptide in Premenarcheal Girls: A Randomized Controlled Trial.
Berger PK; Pollock NK; Laing EM; Chertin V; Bernard PJ; Grider A; Shapses SA; Ding KH; Isales CM; Lewis RD
J Nutr; 2015 Dec; 145(12):2699-704. PubMed ID: 26491117
[TBL] [Abstract][Full Text] [Related]
7. Effects of two years of growth hormone (GH) replacement therapy on bone metabolism and mineral density in childhood and adulthood onset GH deficient patients.
Longobardi S; Di Rella F; Pivonello R; Di Somma C; Klain M; Maurelli L; Scarpa R; Colao A; Merola B; Lombardi G
J Endocrinol Invest; 1999 May; 22(5):333-9. PubMed ID: 10401706
[TBL] [Abstract][Full Text] [Related]
8. Comparison of two automated assays of BTM (CTX and P1NP) and reference intervals in a Danish population.
Jørgensen NR; Møllehave LT; Hansen YBL; Quardon N; Lylloff L; Linneberg A
Osteoporos Int; 2017 Jul; 28(7):2103-2113. PubMed ID: 28455749
[TBL] [Abstract][Full Text] [Related]
9. Bone turnover marker reference intervals in young females.
Callegari ET; Gorelik A; Garland SM; Chiang CY; Wark JD
Ann Clin Biochem; 2017 Jul; 54(4):438-447. PubMed ID: 27496795
[TBL] [Abstract][Full Text] [Related]
10. Bone turnover markers in children and adolescents with type 1 diabetes-A systematic review.
Madsen JOB; Jørgensen NR; Pociot F; Johannesen J
Pediatr Diabetes; 2019 Aug; 20(5):510-522. PubMed ID: 30941847
[TBL] [Abstract][Full Text] [Related]
11. [Serum osteocalcin and bone alkaline phosphatase in healthy children in relation to age and gender].
Ambroszkiewicz J; Gajewska J; Laskowska-Klita T
Med Wieku Rozwoj; 2002; 6(3):257-65. PubMed ID: 12637780
[TBL] [Abstract][Full Text] [Related]
12. Sex- and age-specific reference curves for serum markers of bone turnover in healthy children from 2 months to 18 years.
Rauchenzauner M; Schmid A; Heinz-Erian P; Kapelari K; Falkensammer G; Griesmacher A; Finkenstedt G; Högler W
J Clin Endocrinol Metab; 2007 Feb; 92(2):443-9. PubMed ID: 17105843
[TBL] [Abstract][Full Text] [Related]
13. Biochemical markers of bone turnover in girls during puberty.
Blumsohn A; Hannon RA; Wrate R; Barton J; al-Dehaimi AW; Colwell A; Eastell R
Clin Endocrinol (Oxf); 1994 May; 40(5):663-70. PubMed ID: 7516828
[TBL] [Abstract][Full Text] [Related]
14. Variation of Bone Turnover Markers in Childhood and Adolescence.
Zhang Y; Zhang J; Huang X; Yu X; Li Y; Yu F; Zhou W
Int J Clin Pract; 2023; 2023():5537182. PubMed ID: 37547099
[TBL] [Abstract][Full Text] [Related]
15. Increased serum concentrations of type I procollagen C-terminal propeptide and osteocalcin during a short course of calcitriol administration to adult male volunteers.
Gram J; Bollerslev J; Nielsen HK; Junker P
Acta Endocrinol (Copenh); 1991 Dec; 125(6):609-13. PubMed ID: 1789055
[TBL] [Abstract][Full Text] [Related]
16. Bone turnover markers during the remission phase in children and adolescents with type 1 diabetes.
Madsen JOB; Herskin CW; Zerahn B; Jensen AK; Jørgensen NR; Olsen BS; Svensson J; Pociot F; Johannesen J
Pediatr Diabetes; 2020 Mar; 21(2):366-376. PubMed ID: 31840392
[TBL] [Abstract][Full Text] [Related]
17. Children and adolescents with obesity have reduced serum bone turnover markers and 25-hydroxyvitamin D but increased parathyroid hormone concentrations - Results derived from new pediatric reference ranges.
Geserick M; Vogel M; Eckelt F; Schlingmann M; Hiemisch A; Baber R; Thiery J; Körner A; Kiess W; Kratzsch J
Bone; 2020 Mar; 132():115124. PubMed ID: 31830529
[TBL] [Abstract][Full Text] [Related]
18. Bone formation markers in adults with mild osteogenesis imperfecta.
Cundy T; Horne A; Bolland M; Gamble G; Davidson J
Clin Chem; 2007 Jun; 53(6):1109-14. PubMed ID: 17434905
[TBL] [Abstract][Full Text] [Related]
19. Bone metabolism markers and bone mass in healthy pubertal boys and girls.
van Coeverden SC; Netelenbos JC; de Ridder CM; Roos JC; Popp-Snijders C; Delemarre-van de Waal HA
Clin Endocrinol (Oxf); 2002 Jul; 57(1):107-16. PubMed ID: 12100078
[TBL] [Abstract][Full Text] [Related]
20. The amino-terminal propeptide (PINP) of type I collagen is a clinically valid indicator of bone turnover and extent of metastatic spread in osseous metastatic breast cancer.
Pollmann D; Siepmann S; Geppert R; Wernecke KD; Possinger K; Lüftner D
Anticancer Res; 2007; 27(4A):1853-62. PubMed ID: 17649784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
